Loading... 2 0 5 0 false
Credit Name
Mark Horrigan
Full Name
Horrigan, Mark
Loading... 3 0 5 0 false


Results 1-16 of 16 (Search time: 0.009 seconds).

Publication YearTitleAuthor(s)
126-Mar-2021Safety and Long-Term Clinical Outcomes of Fractional Flow Reserve Guided Coronary Revascularisation.Scully, Timothy G; Toner, Liam ; Yeoh, Julian; Farouque, Omar ; Yudi, Matias B ; Horrigan, Mark ; Clark, David J 
219-Feb-2021Cardiac risk stratification in liver transplantation: results of a tiered assessment protocol based on traditional cardiovascular risk factors.Robertson, Marcus; Chung, William; Liu, Dorothy ; Seagar, Rosemary; O'Halloran, Tess; Koshy, Anoop N ; Horrigan, Mark ; Farouque, Omar ; Gow, Paul J ; Angus, Peter W 
3Jan-2021Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation.Koshy, Anoop N ; Enayati, Anees ; Weinberg, Laurence ; Han, Hui-Chen ; Horrigan, Mark ; Gow, Paul J ; Ko, Jefferson ; Thijs, Vincent N ; Testro, Adam G ; Lim, Han S ; Farouque, Omar ; Teh, Andrew W 
4Oct-2020Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges.Anderson, James; Lavender, Melanie; Lau, Edmund; Celermajer, David; Collins, Nicholas; Dwyer, Nathan; Feenstra, John; Horrigan, Mark ; Keating, Dominic; Keogh, Anne; Kotlyar, Eugene; Ng, Benjamin; Proudman, Susanna; Steele, Peter; Thakkar, Vivek; Weintraub, Robert; Whitford, Helen; Williams, Trevor; Wrobel, Jeremy; Strange, Geoff
54-Jun-2020Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.Murphy, Alexandra C ; Koshy, Anoop N ; Cameron, William; Horrigan, Mark ; Kearney, Leighton; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B 
615-May-2020Meta-analysis Comparing Valve-In-Valve Transcatheter Aortic Valve Implantation With Self-Expanding Versus Balloon-Expandable Valves.Hamilton, Garry W ; Koshy, Anoop N ; Fulcher, Jordan ; Tang, Gilbert H L; Bapat, Vinayak; Murphy, Alexandra C ; Horrigan, Mark ; Farouque, Omar ; Yudi, Matias B 
78-Apr-2020Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.Koshy, Anoop N ; Murphy, Alexandra C ; Farouque, Omar ; Horrigan, Mark ; Yudi, Matias B 
830-Jan-2020Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry.Khou, Victor; Anderson, James J; Strange, Geoff; Corrigan, Carolyn; Collins, Nicholas; Celermajer, David S; Dwyer, Nathan; Feenstra, John; Horrigan, Mark ; Keating, Dominic; Kotlyar, Eugene; Lavender, Melanie; McWilliams, Tanya J; Steele, Peter; Weintraub, Robert; Whitford, Helen; Whyte, Ken; Williams, Trevor J; Wrobel, Jeremy P; Keogh, Anne; Lau, Edmund M
926-Sep-2019Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.Anderson, James J; Lau, Edmund M; Lavender, Melanie; Benza, Raymond; Celermajer, David S; Collins, Nicholas; Corrigan, Carolyn; Dwyer, Nathan; Feenstra, John; Horrigan, Mark ; Keating, Dominic; Kermeen, Fiona; Kotlyar, Eugene; McWilliams, Tanya; Rhodes, Bronwen; Steele, Peter; Thakkar, Vivek; Williams, Trevor; Whitford, Helen; Whyte, Kenneth; Weintraub, Robert; Wrobel, Jeremy P; Keogh, Anne; Strange, Geoff
109-Aug-2019Rare cause of pulmonary hypertension - pulmonary tumour thrombotic microangiopathy.O'Brien, Joseph M; Jones, Nicholas ; Horrigan, Mark ; Al-Kaisey, Ahmed M
11Dec-2018Feasibility of using ultra-low pulse rate fluoroscopy during routine diagnostic coronary angiography.Badawy, Mohamed Khaldoun; Scott, Matthew; Farouque, Omar ; Horrigan, Mark ; Clark, David J ; Chan, Robert K 
1228-Feb-2017Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry.Eccleston, David; Horrigan, Mark ; Rafter, Tony; Holt, Geoffrey; Worthley, Stephen G; Sage, Peter; Whelan, Alan; Reid, Christopher; Thompson, Peter L
1314-Sep-2016The receptor for advanced glycation end products (RAGE) is associated with persistent atrial fibrillationLancefield, Terase F; Patel, Sheila K ; Freeman, Melanie; Velkoska, Elena; Wai, Bryan; Srivastava, Piyush M ; Horrigan, Mark ; Farouque, Omar ; Burrell, Louise M 
141-Jul-2016Management of patients ≥85 years of age with ST-elevation myocardial infarctionYudi, Matias B ; Jones, N ; Fernando, Dharsh; Clark, David J ; Ramchand, Jay ; Jones, Elizabeth F ; Dakis, R; Johnson, Douglas F; Chan, Robert K ; Islam, Amirul; Farouque, Omar ; Horrigan, Mark 
151-Jul-2009Advances in percutaneous treatment for adult valvular heart disease.Wong, M C G; Clark, David J ; Horrigan, Mark ; Grube, E; Matalanis, George ; Farouque, Omar 
1612-Oct-2005What is the best contemporary treatment for in-stent restenosis?Barlis, Peter; Horrigan, Mark ; Chan, Robert K ; Ajani, Andrew E; Proimos, George; Schumer, Wendy A; van Gaal, William J; Rowe, Michael; Eccleston, David; Yan, Bryan B P; Mun Cheong, Yu; Oliver, Les E; Clark, David J